8-KOther Events

WELLTOWER INC. 8-K Report, Corporate Update (Mar 21, 2012)

Filed March 21, 2012For Securities:WELL

Summary

This 8-K filing from Health Care REIT, Inc. (now Welltower Inc.) on March 20, 2012, primarily reports on a new Rule 10b5-1 trading plan established by its Chairman, CEO, and President, George L. Chapman. This plan allows for the systematic sale of company stock and exercise of stock options over a defined period, designed to comply with insider trading regulations. The plan aims to provide an affirmative defense against insider trading allegations by ensuring trades are executed at times when the executive is not in possession of material non-public information. Investors should note that this filing is procedural and relates to the trading activities of a key executive, not a new business development or financial performance announcement. The plan covers a substantial number of shares and options, with sales occurring over a period extending into early 2013. Details of actual trades executed under this plan will be reported separately on Form 4 filings.

Key Highlights

  • 1George L. Chapman, Chairman, CEO, and President, has established a Rule 10b5-1 trading plan.
  • 2The plan permits the sale of up to 24,476 shares of common stock.
  • 3The plan also allows for the exercise and sale of up to 57,648 shares from stock options.
  • 4The trading plan is in effect from April 16, 2012, to February 15, 2013.
  • 5The plan is designed to comply with SEC Rule 10b5-1, providing an affirmative defense against insider trading claims.
  • 6Monthly share sales under the plan range from 15,664 to 26,353 shares, excluding carryovers.
  • 7Actual trade details will be reported on Form 4 filings.

Frequently Asked Questions

A Rule 10b5-1 trading plan is a written document adopted by an insider (like a company executive) that pre-determines the purchase or sale of securities. It must be established at a time when the insider is not aware of material non-public information. These plans provide an affirmative defense against insider trading accusations by demonstrating that trades were made pursuant to a pre-existing, objective plan.

This filing is important because it informs investors about the planned selling activity of a key executive. While the plan is designed to comply with regulations and is not necessarily a negative signal about the company's future, it does indicate that a significant number of shares may be sold by management over the next year. Investors should monitor these sales and consider them in conjunction with other company news and financial performance.

No, the plan allows for the sale of *up to* a specified number of shares and options. The plan specifies a range of monthly sales and also includes provisions for exercising options. It is important to note that the plan also covers the exercise and holding of 4,509 shares. Actual sales will be detailed in subsequent Form 4 filings.

The details of actual sales conducted under this Rule 10b5-1 plan will be reported by Mr. Chapman on Form 4 filings with the SEC. These filings are typically made within two business days of the trade execution.